Skip to content

AbCellera Biologics Inc. ABCL Effective Income Tax Rate Reconciliation, Other Adjustments, Amount

Effective Income Tax Rate Reconciliation, Other Adjustments, Amount at other companies

Zymeworks logo
ZymeworksZYME
ADMA Biologics logo
ADMA BiologicsADMA
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX

Other financials

Income statement

See full
Revenue$8.3M+96.3%
Operating income-$57.5M+8.2%
Net income-$43.2M+5.4%
EPS (diluted)-$0.14+6.7%

Balance sheet

See full
Cash & equivalents$102.1M-44.6%
Total debt$140.2M+107%
Total equity$938.1M-8.3%
Total assets$1.3B-2.8%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$3.8M-64.0%
Free cash flow-$37.4M-68.3%

Valuation

See full
Market cap$1.84B+59.2%

Profitability

See full
Operating margin-267.6%-120pp
Net margin-181.7%-77.9pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-14.7%-0.8pp
Debt / equity0.1×+0.1×
Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationOtherAdjustments.

The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s effective income tax rate reconciliation, other adjustments, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbCellera Biologics Inc.'s effective income tax rate reconciliation, other adjustments, amount?
AbCellera Biologics Inc. (ABCL) reported effective income tax rate reconciliation, other adjustments, amount of $63K in Q4 2025.
How has AbCellera Biologics Inc.'s effective income tax rate reconciliation, other adjustments, amount changed year-over-year?
AbCellera Biologics Inc.'s effective income tax rate reconciliation, other adjustments, amount increased by 227.3% year-over-year, from $19.25K to $63K.
What is the long-term trend for AbCellera Biologics Inc.'s effective income tax rate reconciliation, other adjustments, amount?
Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s effective income tax rate reconciliation, other adjustments, amount has grown at a -20.1% compound annual growth rate (CAGR), from -$395K to $252K.